- Home
- WHD vs RXRX Comparison
WHD vs RXRX Comparison
Compare WHD & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- RXRX
- Stock Information
- Founded
- WHD 2011
- RXRX 2013
- Country
- WHD United States
- RXRX United States
- Employees
- WHD N/A
- RXRX N/A
- Industry
- WHD Metal Fabrications
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- WHD Industrials
- RXRX Health Care
- Exchange
- WHD Nasdaq
- RXRX Nasdaq
- Market Cap
- WHD 2.7B
- RXRX 2.6B
- IPO Year
- WHD 2018
- RXRX 2021
- Fundamental
- Price
- WHD $41.03
- RXRX $4.39
- Analyst Decision
- WHD Hold
- RXRX Buy
- Analyst Count
- WHD 6
- RXRX 5
- Target Price
- WHD $52.33
- RXRX $7.60
- AVG Volume (30 Days)
- WHD 908.9K
- RXRX 23.1M
- Earning Date
- WHD 04-30-2025
- RXRX 05-05-2025
- Dividend Yield
- WHD 1.27%
- RXRX N/A
- EPS Growth
- WHD 11.86
- RXRX N/A
- EPS
- WHD 2.83
- RXRX N/A
- Revenue
- WHD $1,136,010,000.00
- RXRX $59,790,000.00
- Revenue This Year
- WHD $1.34
- RXRX $57.30
- Revenue Next Year
- WHD $5.85
- RXRX $51.53
- P/E Ratio
- WHD $14.48
- RXRX N/A
- Revenue Growth
- WHD N/A
- RXRX 29.32
- 52 Week Low
- WHD $33.80
- RXRX $3.79
- 52 Week High
- WHD $70.01
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- WHD 52.34
- RXRX 36.98
- Support Level
- WHD $39.38
- RXRX $4.11
- Resistance Level
- WHD $40.83
- RXRX $5.90
- Average True Range (ATR)
- WHD 1.42
- RXRX 0.39
- MACD
- WHD 0.73
- RXRX -0.11
- Stochastic Oscillator
- WHD 97.06
- RXRX 14.00
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.